restor3d: Pioneering the Future of Orthopedic Care with Personalized 3D Printed Implants
June 6, 2024, 3:36 pm
Location: United States, North Carolina, Durham
Employees: 51-200
Founded date: 2017
Total raised: $93M
In a groundbreaking move, restor3d, a cutting-edge company based in Durham, North Carolina, has recently secured a substantial $70 million in funding to advance its mission of revolutionizing orthopedic care through the development of personalized 3D printed implants. Spearheaded by the visionary CEO Kurt Jacobus, restor3d is on a mission to transform the landscape of orthopedic medicine by offering innovative solutions that are tailored to meet the unique needs of individual patients.
The $70 million funding package includes a $55 million Series A funding round led by private investors such as Summers Value Partners, as well as an additional $15 million in debt financing led by Trinity Capital. This significant investment will serve as a catalyst for the company's growth and innovation in several key areas, positioning restor3d as a leader in the field of personalized orthopedic implants.
One of the primary focuses of restor3d's expansion efforts is the development and release of new patient-specific 3D printed implant systems. These cutting-edge systems will cater to a range of orthopedic needs, including total ankle and shoulder replacements. By leveraging the power of 3D printing technology, restor3d aims to provide patients with customized implant solutions that are designed to fit their unique anatomy and address their specific pathology.
In addition to enhancing its implant offerings, restor3d is also committed to investing in advanced 3D printing technologies to expand its in-house production capabilities. By streamlining the 'powder to sterile product' production process, the company aims to increase its capacity for growth while simultaneously reducing production costs and shortening personalized implant delivery times.
Furthermore, restor3d is dedicated to improving its software and design automation solutions to streamline case intake and design processes. By leveraging sophisticated software tools, the company aims to accelerate digital design times and enhance service levels for surgeons and their patients. This commitment to innovation and efficiency underscores restor3d's dedication to providing the highest quality care to its patients.
Beyond its technological advancements, restor3d is also focused on advancing medical education and training in the field of orthopedic and reconstructive surgery. The company's new funding will enable the expansion of its educational initiatives, providing surgeons and sales teams with comprehensive training on the latest technologies and surgical techniques. By investing in education, restor3d aims to empower healthcare professionals to deliver the best possible care to their patients.
In a statement reflecting on the recent funding round, CEO Kurt Jacobus expressed gratitude for the support of restor3d's investors and highlighted the company's commitment to transforming orthopedic care through personalized 3D printed implants. With a clear vision and a dedication to innovation, restor3d is poised to make a lasting impact on the future of orthopedic medicine, improving patient outcomes and advancing the standard of care in the field.
The $70 million funding package includes a $55 million Series A funding round led by private investors such as Summers Value Partners, as well as an additional $15 million in debt financing led by Trinity Capital. This significant investment will serve as a catalyst for the company's growth and innovation in several key areas, positioning restor3d as a leader in the field of personalized orthopedic implants.
One of the primary focuses of restor3d's expansion efforts is the development and release of new patient-specific 3D printed implant systems. These cutting-edge systems will cater to a range of orthopedic needs, including total ankle and shoulder replacements. By leveraging the power of 3D printing technology, restor3d aims to provide patients with customized implant solutions that are designed to fit their unique anatomy and address their specific pathology.
In addition to enhancing its implant offerings, restor3d is also committed to investing in advanced 3D printing technologies to expand its in-house production capabilities. By streamlining the 'powder to sterile product' production process, the company aims to increase its capacity for growth while simultaneously reducing production costs and shortening personalized implant delivery times.
Furthermore, restor3d is dedicated to improving its software and design automation solutions to streamline case intake and design processes. By leveraging sophisticated software tools, the company aims to accelerate digital design times and enhance service levels for surgeons and their patients. This commitment to innovation and efficiency underscores restor3d's dedication to providing the highest quality care to its patients.
Beyond its technological advancements, restor3d is also focused on advancing medical education and training in the field of orthopedic and reconstructive surgery. The company's new funding will enable the expansion of its educational initiatives, providing surgeons and sales teams with comprehensive training on the latest technologies and surgical techniques. By investing in education, restor3d aims to empower healthcare professionals to deliver the best possible care to their patients.
In a statement reflecting on the recent funding round, CEO Kurt Jacobus expressed gratitude for the support of restor3d's investors and highlighted the company's commitment to transforming orthopedic care through personalized 3D printed implants. With a clear vision and a dedication to innovation, restor3d is poised to make a lasting impact on the future of orthopedic medicine, improving patient outcomes and advancing the standard of care in the field.